Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Zealand Pharma

287.90 DKK

+0.07 %

Less than 1K followers

ZEAL

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.07 %
-19.92 %
-38.27 %
-40.39 %
-34.43 %
-49.09 %
+26.38 %
+50.50 %
+262.14 %

Zealand Pharma operates in biotechnology. Special focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest operations are in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Søborg, Denmark.

Read more
Market cap
20.59B DKK
Turnover
89.2M DKK
Revenue
9.21B
EBIT %
75.52 %
P/E
3.14
Dividend yield-%
-
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

All
Research
Press releases
ShowingAll content types
Regulatory press release7 hours ago

Resolutions from Zealand Pharma's Annual General Meeting 2026

Zealand Pharma
Regulatory press release3/19/2026, 9:00 PM

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

Zealand Pharma
HCA Morgenbørs 19/03 - Negative futures drevet af olieudviklingen
Video3/19/2026, 8:31 AM by
Michael Friis, Victor Skriver

HCA Morgenbørs 19/03 - Negative futures drevet af olieudviklingen

I dagens Morgenbørs ser vi negative futures fra morgenstunden, nattens angreb er nu gået fra kun at ødelægge distribution til reelle olieaktiver. Herhjemme fokus på blandt negative analytiker ændringer.

Novo NordiskColoplastFLSmidth & Co.Zealand PharmaNKTDanish Aerospace CompanyWirtekGreenMobilityBioPorto

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
HCA Morgenbørs 13/03 - Olieprisen og Nvidia sætter retningen
Video3/17/2026, 8:22 AM by
Michael Friis, Rasmus Køjborg

HCA Morgenbørs 13/03 - Olieprisen og Nvidia sætter retningen

I dagens Morgenbørs ser vi ind i små fald, hvor olieprisen og Nvidia sætter retningen. Herhjemme fokus på GN Store Nord og Novo Nordisk.

GN Store NordGubraZealand PharmaNovo NordiskTormNTG Nordic Transport GroupRoblon
HCA Morgenbørs 09/03 - Et store fald på futures fronten, oliepriser har krydset 100 og øget nervøsitet omkring finansiering af AI udbygningen
Video3/10/2026, 8:26 AM by
Rasmus Køjborg, Michael Friis

HCA Morgenbørs 09/03 - Et store fald på futures fronten, oliepriser har krydset 100 og øget nervøsitet omkring finansiering af AI udbygningen

I dagens Morgenbørs ser vi ind i et store fald på futures fronten, oliepriser har krydset 100 og øget nervøsitet omkring finansiering af AI udbygningen. Herhjemme, fokus på bl.a. Novo, Zealand, høreapparatsproducenterne.

TormHafniaD/S NordenGubraRockwoolRoyal UnibrewZealand Pharma
HCA Morgenbørs 10/03 - Europæiske futures indikerer et re-bound
Video3/10/2026, 8:15 AM by
Michael Friis, Rasmus Køjborg

HCA Morgenbørs 10/03 - Europæiske futures indikerer et re-bound

I dagens Morgenbørs ser vi ind i europæiske futures der indikerer et re-bound ovenpå Trumps kommentarer omkring længde på konflikten. Herhjemme, fokus på blandt andet Novo, Gubra og taberne på stigende oliepris.

RockwoolDSVNTG Nordic Transport GroupScandinavian Tobacco GroupDanske BankNovo NordiskGubraZealand Pharma
HCA Morgenbørs 06/03 - Investorerne finder lidt ro efter en uge præget af usikkerhed
Video3/6/2026, 8:25 AM by
Victor Skriver, Philip Coombes

HCA Morgenbørs 06/03 - Investorerne finder lidt ro efter en uge præget af usikkerhed

I dagens morgenbørs ser vi ind i positive futures, hvor investorerne slutter ugen med at finde lidt ro efter en uge præget af usikkerhed. Fokus herhjemme bliver på Zealand Pharma og en række kursmålsjusteringer.

Zealand PharmaFLSmidth & Co.TormDSVScandinavian Tobacco GroupDanish Aerospace Company
Regulatory press release3/5/2026, 6:45 PM

Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity

Zealand Pharma
Regulatory press release2/19/2026, 1:00 PM

Zealand Pharma convenes its Annual General Meeting 2026

Zealand Pharma
HCA Morgenbørs 19/02 - Fokus på dagens regnskaber
Video2/19/2026, 8:35 AM by
Victor Skriver, Philip Coombes

HCA Morgenbørs 19/02 - Fokus på dagens regnskaber

I dagens Morgenbørs ser vi ind i negative futures-markeder i Europa. Herhjemme er der fokus på regnskabsaktuelle ISS, Zealand Pharma, DFDS, Nilfisk og GomSpace.

ISSZealand PharmaDFDSNilfisk HoldingGomSpace GroupExpreS2ion Biotech Holding
Regulatory press release2/19/2026, 6:00 AM

Zealand Pharma Announces Financial Results for the Full Year 2025

Zealand Pharma
HCA Morgenbørs 09/01 - Futures peger op i Europa og fokus på afgørelse om Trumps tariffer
Video1/9/2026, 8:28 AM by
Rasmus Køjborg, Philip Coombes

HCA Morgenbørs 09/01 - Futures peger op i Europa og fokus på afgørelse om Trumps tariffer

I dagens Morgenbørs ser vi ind i US futures der ligger marginalt i minus, mens EU peger op fra morgenstunden. Afventende stemning op til at højesteret i USA kommer med afgørelse om Trumps tariffer.

GubraZealand PharmaLundbeckGrønlandsbankenHafniaTorm
Press release1/9/2026, 7:00 AM

Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy

Zealand Pharma
Press release1/5/2026, 4:05 PM

Zealand Pharma to present at the J.P. Morgan Healthcare Conference

Zealand Pharma
Regulatory press release12/31/2025, 4:05 PM

Total number of shares and voting rights in Zealand Pharma as of December 31, 2025

Zealand Pharma
Regulatory press release12/19/2025, 9:00 PM

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Zealand Pharma
Regulatory press release12/11/2025, 9:00 PM

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

Zealand Pharma
HCA Morgenbørs 11/12 - Flade europæiske futures, Oracle skaber usikkerhed om AI
Video12/11/2025, 8:45 AM by
Michael Friis, Philip Coombes

HCA Morgenbørs 11/12 - Flade europæiske futures, Oracle skaber usikkerhed om AI

I dagens Morgenbørs ser vi ind i flade europæiske futures, Oracle skaber usikkerhed om AI. Herhjemme fokus på blandt andet Nilfisk der har fået et overtagelsesbud og Zealand (CMD).

GreenMobilityNilfisk HoldingZealand Pharma
Press release12/11/2025, 6:05 AM

Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health

Zealand Pharma
Press release12/11/2025, 6:00 AM

Zealand Pharma and OTR Therapeutics enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases

Zealand Pharma
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.